| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |